According to the National Academy of Medicine , the most commonly prescribed GLP-1 agonists include: Ozempic (semaglutide) Wegovy (semaglutide) Mounjaro (tirzepatide) Zepbound (tirzepatide) Apart from these, some other brands include the following: Rybelsus (semaglutide) Victoza (liraglutide) Saxenda (liraglutide) Xultophy (liraglutide) Trulicity (dulaglutide) Byetta (exenatide) Bydureon (exenatide) While learning about GLP-1 vs Ozempic, keep in mind that all of them are FDA-approved as prescription medications
Some users may indeed respond better to one form based on genetic or metabolic factors
They are undertreated because trial populations have historically skewed male
That is necessary but insufficient
Weight reduction alone does not reverse central sensitization, the core mechanism of fibromyalgia, making GLP-1 therapy insufficient as a primary pain management strategy
Millions of people are achieving meaningful weight loss, improved insulin sensitivity, and reduced inflammation thanks to these drugs